EYE » Topics » Cataract/Implant sales rose 9.6% to $152.3 million in the quarter and 6.4% to $552.0 million for 2007.
This excerpt taken from the EYE 8-K filed Feb 14, 2008.
Cataract/Implant sales rose 9.6% to $152.3 million in the quarter and 6.4% to $552.0 million for 2007.
Intraocular lens (IOL) sales rose 7.6% to $85.7 million in the quarter and 8.8% to $317.2 million for 2007, reflecting
continuing demand for the companys Tecnis® monofocal IOLs and its portfolio of refractive IOLs.
Viscoelastics sales rose 9.7% to $33.6 million in the quarter and 0.3% to $123.4 million for 2007. Growth was driven
primarily by increased sales of the Healon® family of viscoleastics.
Phacoemulsification sales rose 10.7% to $26.4 million in the quarter and 3.6% to $90.7 million for 2007. The rise
reflected the mid-year launch of the WhiteStar SignatureTM system and increased surgeon usage of the companys existing phacoemulsification installed
base. Surgical pack sales rose 12.9% in the quarter and 9.5% for 2007.
How risky is your portfolio?
Remember that 401k from 2 jobs ago?
Taking on too much risk? Too little risk? Have no idea?
Skip the spreadsheet. Track your investments automatically.
We tally your portfolio fees so you don't have to.
You're probably paying higher fees than you think.
Translate your investment accounts from Martian to English.